Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Neutrophil Extracellular Traps (NETs) in the Cerebrospinal Fluid Samples from Children and Adults with Central Nervous System Infections.

Appelgren D, Enocsson H, Skogman BH, Nordberg M, Perander L, Nyman D, Nyberg C, Knopf J, Muñoz LE, Sjöwall C, Sjöwall J.

Cells. 2019 Dec 23;9(1). pii: E43. doi: 10.3390/cells9010043.

2.

Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.

Enocsson H, Wirestam L, Dahle C, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma AA, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, van Vollenhoven RF, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken CA, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.

J Autoimmun. 2020 Jan;106:102340. doi: 10.1016/j.jaut.2019.102340. Epub 2019 Oct 17.

3.

Salivary and plasma levels of matrix metalloproteinase-9 and myeloperoxidase at rest and after acute physical exercise in patients with coronary artery disease.

Mahmood Z, Enocsson H, Bäck M, Chung RWS, Lundberg AK, Jonasson L.

PLoS One. 2019 Feb 6;14(2):e0207166. doi: 10.1371/journal.pone.0207166. eCollection 2019.

4.

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

Wirestam L, Enocsson H, Skogh T, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace D, Isenberg DA, Rahman A, Merrill J, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma A, Ruiz-Irastorza G, Lim S, Kalunian K, Inanc M, van Vollenhoven R, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken C, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.

J Rheumatol. 2019 May;46(5):492-500. doi: 10.3899/jrheum.180713. Epub 2019 Jan 15.

5.

Osteopontin is associated with disease severity and antiphospholipid syndrome in well characterised Swedish cases of SLE.

Wirestam L, Frodlund M, Enocsson H, Skogh T, Wetterö J, Sjöwall C.

Lupus Sci Med. 2017 Jul 28;4(1):e000225. doi: 10.1136/lupus-2017-000225. eCollection 2017.

6.

Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.

Wirestam L, Enocsson H, Skogh T, Eloranta ML, Rönnblom L, Sjöwall C, Wetterö J.

Clin Exp Immunol. 2017 Jul;189(1):83-91. doi: 10.1111/cei.12957. Epub 2017 Mar 31.

7.

Soluble urokinase plasminogen activator receptor--a valuable biomarker in systemic lupus erythematosus?

Enocsson H, Sjöwall C, Wetterö J.

Clin Chim Acta. 2015 Apr 15;444:234-41. doi: 10.1016/j.cca.2015.02.031. Epub 2015 Feb 19. Review.

8.

Four Anti-dsDNA Antibody Assays in Relation to Systemic Lupus Erythematosus Disease Specificity and Activity.

Enocsson H, Sjöwall C, Wirestam L, Dahle C, Kastbom A, Rönnelid J, Wetterö J, Skogh T.

J Rheumatol. 2015 May;42(5):817-25. doi: 10.3899/jrheum.140677. Epub 2015 Feb 15.

9.

Association of serum C-reactive protein levels with lupus disease activity in the absence of measurable interferon-α and a C-reactive protein gene variant.

Enocsson H, Sjöwall C, Kastbom A, Skogh T, Eloranta ML, Rönnblom L, Wetterö J.

Arthritis Rheumatol. 2014 Jun;66(6):1568-73. doi: 10.1002/art.38408.

10.

Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.

Enocsson H, Wetterö J, Skogh T, Sjöwall C.

Transl Res. 2013 Nov;162(5):287-96. doi: 10.1016/j.trsl.2013.07.003. Epub 2013 Aug 1.

PMID:
23916811
11.

High prevalence of autoantibodies to C-reactive protein in patients with chronic hepatitis C infection: association with liver fibrosis and portal inflammation.

Sjöwall C, Cardell K, Boström EA, Bokarewa MI, Enocsson H, Ekstedt M, Lindvall L, Frydén A, Almer S.

Hum Immunol. 2012 Apr;73(4):382-8. doi: 10.1016/j.humimm.2012.01.009. Epub 2012 Feb 1.

PMID:
22333691
12.

Designed surface with tunable IgG density as an in vitro model for immune complex mediated stimulation of leukocytes.

Kanmert D, Enocsson H, Wetterö J, Kastbom A, Skogh T, Enander K.

Langmuir. 2010 Mar 2;26(5):3493-7. doi: 10.1021/la9030766.

PMID:
20000861
13.

Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares?

Enocsson H, Sjöwall C, Skogh T, Eloranta ML, Rönnblom L, Wetterö J.

Arthritis Rheum. 2009 Dec;60(12):3755-60. doi: 10.1002/art.25042.

Supplemental Content

Loading ...
Support Center